These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9089428)
1. Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough. Chan P; Tomlinson B; Huang TY; Ko JT; Lin TS; Lee YS J Clin Pharmacol; 1997 Mar; 37(3):253-7. PubMed ID: 9089428 [TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensive patients with a previous angiotensin converting enzyme inhibitor-associated cough. Ramsay LE; Yeo WW; J Hypertens Suppl; 1995 Jul; 13(1):S73-6. PubMed ID: 18800460 [TBL] [Abstract][Full Text] [Related]
3. Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. Lacourcière Y; Brunner H; Irwin R; Karlberg BE; Ramsay LE; Snavely DB; Dobbins TW; Faison EP; Nelson EB J Hypertens; 1994 Dec; 12(12):1387-93. PubMed ID: 7706699 [TBL] [Abstract][Full Text] [Related]
4. ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. Ramsay LE; Yeo WW J Hum Hypertens; 1995 Nov; 9 Suppl 5():S51-4. PubMed ID: 8583482 [TBL] [Abstract][Full Text] [Related]
5. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266 [TBL] [Abstract][Full Text] [Related]
6. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors. Paster RZ; Snavely DB; Sweet AR; Draper RA; Goldberg AI; Soffer BA; Sweet CS Clin Ther; 1998; 20(5):978-89. PubMed ID: 9829449 [TBL] [Abstract][Full Text] [Related]
7. Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. Benz J; Oshrain C; Henry D; Avery C; Chiang YT; Gatlin M J Clin Pharmacol; 1997 Feb; 37(2):101-7. PubMed ID: 9055135 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Goldberg AI; Dunlay MC; Sweet CS Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281 [TBL] [Abstract][Full Text] [Related]
9. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group. Lacourciére Y Int J Clin Pract; 1999 Mar; 53(2):99-103. PubMed ID: 10344043 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. Tikkanen I; Omvik P; Jensen HA J Hypertens; 1995 Nov; 13(11):1343-51. PubMed ID: 8984133 [TBL] [Abstract][Full Text] [Related]
11. Modulation of the renin-angiotensin-aldosterone system and cough. Lacourcière Y; Lefebvre J Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216 [TBL] [Abstract][Full Text] [Related]
12. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension. Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492 [TBL] [Abstract][Full Text] [Related]
13. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group. Tanser PH; Campbell LM; Carranza J; Karrash J; Toutouzas P; Watts R Am J Hypertens; 2000 Feb; 13(2):214-8. PubMed ID: 10701823 [TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension. Ishimitsu T; Yagi S; Ebihara A; Doi Y; Domae A; Shibata A; Kimura M; Sugishita Y; Sagara E; Sakamaki T; Murata K Jpn Heart J; 1997 Nov; 38(6):831-40. PubMed ID: 9486936 [TBL] [Abstract][Full Text] [Related]
15. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. Weiss RJ; Stapff M; Lin Y Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Pylypchuk GB Ann Pharmacother; 1998 Oct; 32(10):1060-6. PubMed ID: 9793599 [TBL] [Abstract][Full Text] [Related]
17. Losartan: first of a new class of angiotensin antagonists for the management of hypertension. Carr AA; Prisant LM J Clin Pharmacol; 1996 Jan; 36(1):3-12. PubMed ID: 8932538 [TBL] [Abstract][Full Text] [Related]
18. The angiotensin II type 1 receptor blocker losartan in clinical practice: a review. Gavras HP; Salerno CM Clin Ther; 1996; 18(6):1058-67; discussion 1057. PubMed ID: 9001823 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial. Pitt B; Chang P; Timmermans PB Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552 [TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group. Elliott WJ J Hum Hypertens; 1999 Jun; 13(6):413-7. PubMed ID: 10408592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]